Biogen (BIIB) Current Taxes (2009 - 2026)
Biogen (BIIB) posted quarterly Current Taxes of $86.9 million for Q2 2026, down 24.3% year-over-year from $114.8 million in Q2 2025, and down 7.16% quarter-over-quarter from $93.6 million in Q1 2026.
Biogen (BIIB) Current Taxes (2009 - 2026) Analysis & Trends
Biogen's Current Taxes history runs 18 years deep, the most recent figure standing at $86.9 million for Q2 2026.
- In Q2 2026, Current Taxes fell 24.3% year-over-year to $86.9 million; the TTM figure through Jun 2026 stood at $86.9 million (down 24.3% YoY), while the FY2025 annual figure was $114.8 million, down 79.06% from the prior year.
- Current Taxes for Q2 2026 stood at $86.9 million, down from $93.6 million in the prior quarter.
- The five-year high for Current Taxes was $626.1 million in Q1 2025, with the low at $86.9 million in Q2 2026.
- The 5-year median for Current Taxes is $250.6 million (2023), against an average of $266.4 million.
- The sharpest annual moves came in 2025 and 2026: Current Taxes surged 170.8% in 2025, then slumped 85.05% in 2026.
- Biogen's Current Taxes stood at $259.9 million in 2022, then slipped by 0.96% to $257.4 million in 2023, then soared by 113.01% to $548.3 million in 2024, then sank by 79.06% to $114.8 million in 2025, then decreased by 24.3% to $86.9 million in 2026.
- Business Quant data shows BIIB's Current Taxes at $86.9 million in Q2 2026, $93.6 million in Q1 2026, and $114.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | - |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | 86.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.90 Mn |
| Mar 31, 2026 | 93.60 Mn |
| Dec 31, 2025 | 114.80 Mn |
| Sep 30, 2025 | 103.30 Mn |
| Jun 30, 2025 | 114.80 Mn |
| Mar 31, 2025 | 626.10 Mn |
| Dec 31, 2024 | 548.30 Mn |
| Sep 30, 2024 | 499.10 Mn |
| Jun 30, 2024 | 281.60 Mn |
| Mar 31, 2024 | 231.20 Mn |
| Dec 31, 2023 | 257.40 Mn |
| Sep 30, 2023 | 243.80 Mn |
| Jun 30, 2023 | 260.00 Mn |
| Mar 31, 2023 | 235.50 Mn |
| Dec 31, 2022 | 259.90 Mn |
| Sep 30, 2022 | 237.30 Mn |
| Jun 30, 2022 | 284.90 Mn |
| Mar 31, 2022 | 317.30 Mn |
| Dec 31, 2021 | 174.70 Mn |
| Sep 30, 2021 | 234.20 Mn |